EUVIMEDEUVIMED entdecken
Crossref

Managing myasthenia gravis in dogs and cats

Mark Lowrie

In Practice · 2025-04 · 47 (3) · 116-122

DOI: 10.1002/inpr.525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Practice, online erschienen am 28.03.2025. Verfasst von Mark Lowrie. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Myasthenia gravis (MG) and congenital myasthenic syndromes (CMS) are characterised by severe muscle weakness and impaired neuromuscular transmission. CMS in dogs represent a heterogeneous group of genetic disorders affecting the motor endplate – the specialised synapse between motor neurons and skeletal muscle fibres. These disorders arise from genetic mutations in presynaptic, synaptic and postsynaptic proteins, with clinical presentations and diagnostic criteria varying across breeds. MG, on the other hand, is an autoimmune disease primarily mediated by autoantibodies targeting nicotinic acetylcholine receptors (nAChRs). While most MG patients are seropositive for nAChR antibodies, seronegative cases occur, and the absence of these antibodies does not exclude the diagnosis. Aim of the article: This article reviews the pathophysiology, clinical features and diagnostic approaches for both MG and CMS, along with the role of immunosuppressive therapies and anticholinesterase treatments in managing these conditions. Understanding the molecular basis and treatment strategies for MG and CMS allows for accurate diagnosis and improved outcomes in affected dogs and cats.

Zitieren

APA

Lowrie, M. (2025). Managing myasthenia gravis in dogs and cats. In Practice, 47(3), 116-122. https://doi.org/10.1002/inpr.525

Vancouver

Lowrie M. Managing myasthenia gravis in dogs and cats. In Practice. 2025;47(3):116-122. doi:10.1002/inpr.525

BibTeX
@article{Lowrie2025,
  author = {Lowrie, Mark},
  title = {Managing myasthenia gravis in dogs and cats},
  journal = {In Practice},
  year = {2025},
  volume = {47},
  number = {3},
  pages = {116--122},
  doi = {10.1002/inpr.525}
}
Kostenlos starten →